New research published in Alzheimer’s disease and dementia We provide evidence that genetic variations related to brain fluid movement interact with sleep quality and influence memory and brain structure in older adults. The findings suggest that the influence of a particular genetic profile on Alzheimer’s disease risk may be highly dependent on a person’s sleep quality. This points to sleep as a potential focus for protecting long-term brain health in individuals with certain genetic vulnerabilities.
Alzheimer’s disease is a progressive neurological disease characterized by the gradual accumulation of a toxic protein called amyloid beta in the brain. Over time, this protein clumps together to form solid plaques between nerve cells. These events tend to cause neurotoxicity and lead to the accumulation of another protein called tau. This biological cascade causes severe damage to brain cells, physical tissue shrinkage, progressive cognitive decline, and ultimately dementia.
In a healthy brain, biological mechanisms work continuously to flush out these harmful waste products before they can cause damage. One of the major waste removal networks in the human brain is known as the glymphatic system. The glymphatic system can be thought of as a biological plumbing network that uses the brain’s internal fluids to flush out cellular waste. This system relies heavily on a water channel protein known as aquaporin-4 (AQP4).
This particular protein is found on tiny projections of specialized supporting cells in the brain called astrocytes. From this location, the AQP4 protein acts as a microscopic gatekeeper, regulating the movement of body fluids and flushing out waste products. Research shows that this important brain cleaning process primarily occurs while we are resting in deep sleep. Poor sleep habits tend to limit the brain’s ability to efficiently clear amyloid beta.
Because the AQP4 protein is a key component of this waste removal system, scientists are very interested in the specific gene that holds the biological instructions for building it. Humans naturally have different versions of this gene, with small changes in the DNA sequence. These small genetic differences are called single nucleotide polymorphisms and are passed down through families. Small changes in the DNA sequence can change the amount of AQP4 protein a person makes and the function of that protein.
A research team from Edith Cowan University, the Commonwealth Scientific and Industrial Research Institute, and other institutions organized a project to investigate this biological dynamic. They wanted to know whether different AQP4 gene mutations affect markers such as brain atrophy and cognitive decline. They also aimed to see whether a person’s sleep habits alter how these genetic differences affect physical brain health.
Researchers looked at data from 351 older adults, with an average age of about 75 years. These participants were part of an ongoing research project called the Australian Imaging, Biomarkers and Lifestyle Study. At the beginning of the observation period, all participants had normal memory and thinking ability. However, brain scans showed that she already had significant amyloid beta buildup, which put her at high risk for Alzheimer’s disease.
To measure sleep habits, the scientists used a standard questionnaire that asked participants to rate their sleep quality over the past month. The study recorded details such as how long you slept, how long it took you to fall asleep, and how often your sleep was interrupted. The research team used specialized medical scans to assess the physical state of each participant’s brain. Positron emission tomography (PET scan) enabled the team to measure amyloid beta levels.
The authors also used magnetic resonance imaging (MRI scans) to measure the precise volumes of different regions of the brain. To assess mental performance, participants underwent a comprehensive series of tests that measured multiple areas of thinking. These mental tests assessed executive function, episodic memory, cognition, language skills, and processing speed. Finally, the team analyzed blood samples to determine which version of 13 different AQP4 gene mutations each person carried.
Scientists followed many of these people over several years, monitoring changes in their physical brain health and cognitive abilities over time. During the statistical analysis, the team considered variables such as age, gender, weight, depression, and history of cardiovascular disease. Scientists have found a direct link between genetic variation in AQP4 and mental performance, regardless of sleep habits. People carrying a less common version of a particular genetic mutation called rs162007 were shown to have better overall scores on tests of memory and thinking skills at the start of the study.
No other direct associations between genetic variation alone and brain volume or amyloid beta levels were statistically significant. However, this study reveals several ways that genetics and sleep habits interact to influence physical brain health. For example, gray matter is the outer layer of brain tissue that contains the bodies of nerve cells. Researchers noted that for people with certain genetic variations known as rs151245 and rs2339214, shorter sleep duration is associated with faster gray matter loss over time.
“Our study shows that people who carry certain AQP4 variants have faster gray matter loss when they report less sleep,” said Edith Cowan University researcher Aisha Milligan-Armstrong. For individuals without these specific genetic profiles, reducing sleep time did not result in a similar acceleration of contractions. “It’s not just what genes you have that matters, but how those genes interact with the world around you,” Armstrong said. “The same variant can appear protective or harmful depending on how someone sleeps.”
Armstrong said these interactions highlight concrete paths to intervention. “This is important because sleep is one of the few modifiable factors that people can actually act on,” she says. The researchers also examined the ventricles, the fluid-filled cavities inside the brain. These spaces naturally enlarge as the surrounding brain tissue shrinks due to age or disease.
The authors found that taking longer to fall asleep was associated with larger ventricles, but only in people with a genetic variation called rs7240333. In people with the rs2339214 mutation, poorer overall sleep quality predicted faster expansion of these ventricles over time. White matter is made up of insulated nerve fibers that connect different parts of the brain. Scientists reported that longer sleep duration was associated with smaller white matter volume in people with another variant, rs68006382.
Interestingly, researchers also found that some genetic variants appear to have a protective effect against sleep deprivation. In participants who carried two copies of the rarer version of rs12968026 or rs3875089, the increase in sleep problems actually coincided with a slower rate of cognitive decline.
“We’ve known for some time that sleep deprivation is associated with Alzheimer’s disease risk,” says Edith Cowan University researcher Tenniel Porter. “What this shows is that preventing Alzheimer’s disease may require a more targeted and individualized approach, rather than assuming that everyone at risk follows the same path.”
The lack of association between these genes and changes in amyloid beta levels was somewhat unexpected. Scientists had expected a measurable connection, since the AQP4 protein is believed to help clear this very protein. The authors suggest that because amyloid beta accumulation occurs very slowly over decades, the associated genetic effects may have occurred much earlier in the participants’ lives. By the time this study was conducted, the downstream effects of that accumulation, such as shrinking brain tissue, were becoming more visible.
Readers should remember that this type of observational study cannot prove that sleep deprivation directly causes brain atrophy in people with these genes. This study provides evidence of a relationship but does not definitively establish causation. It is also important to note that the observed differences in brain volume and memory scores were relatively small. Having one of these genetic mutations does not guarantee that you will develop Alzheimer’s disease.
The researchers noted some specific limitations to their methodology. Sleep data relied entirely on self-report questionnaires, which are notoriously subjective. Human memory is often imperfect, and participants may not have been able to accurately recall their exact sleep habits over the past month. Additionally, the sample size for the long-term follow-up portion of the study was somewhat small, which may make it difficult to detect subtle biological changes.
The study group was mostly comprised of white, highly educated people. This lack of diversity means that the results may not apply equally to different populations. The researchers also specifically selected participants who already had significant amyloid beta buildup in their brains. This particular selection criterion means that the findings may not be transmitted to a broader, healthier population.
“However, we are not at the stage to recommend genetic testing; our findings need to be replicated in larger and more diverse cohorts,” Porter said. Understanding the precise biological function of these genetic mutations in a laboratory setting may also help explain how they physically affect the brain. Until then, these findings highlight the potential for personalized medicine in neurological care. Tracking genetic vulnerabilities could ultimately help doctors provide targeted lifestyle recommendations to older adults.
“This brings us closer to understanding why some people decline faster than others, despite on paper having similar risks,” said Simon Laws, director of Edith Cowan University’s Center for Precision Health. “Rather than treating everyone at risk for Alzheimer’s disease the same, identifying who is most vulnerable and who is most likely to benefit from specific lifestyle interventions is where precision medicine comes in.” Taking active steps to improve sleep hygiene may act as a practical safeguard against age-related cognitive decline.
The study, “Evidence for a direct and sleep-regulated relationship between aquaporin-4 gene variation and Alzheimer’s disease phenotype,” was authored by Tenielle Porter, Ayeisha Milligan Armstrong, Eleanor K. O’Brien, Vincent Doré, Pierrick Bourgeat, Mitchell Turner, Paul Maruff, Christopher C. Rowe, Belinda M. Brown, Victor L. Villemagne, and Stephanie. R. Rainey-Smith, Simon M. Laws, and the AIBL Research Group.
